Observational and genetic studies of C-reactive protein levels and risk of Alzheimer's disease
Research output: Contribution to journal › Comment/debate › Research › peer-review
Original language | English |
---|---|
Journal | Alzheimer's and Dementia |
Volume | 18 |
Issue number | 12 |
Pages (from-to) | 2734-2735 |
ISSN | 1552-5260 |
DOIs |
|
Publication status | Published - 2022 |
Bibliographical note
Funding Information:
Sharif H. Hegazy, Jesper Qvist Thomassen, Ida Juul Rasmussen, and Anne Tybjærg‐Hansen have nothing to disclose. Børge G. Nordestgaard received consulting fees (personal fees) from AstraZeneca, Sanofi, Regeneron, Akcea, Amgen, Kowa, Denka, Amarin, Novartis, Novo Nordisk, Esperion, and Silence Therapeutics. RFS received consulting fees (personal fees) from Novo Nordisk. The Lundbeck Foundation, the Danish Heart Foundation, and the Independent Research Fund Denmark. Author disclosures are available in the supporting information.
ID: 325825608